Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Takeshi Ota
Prognostic Significance of the Radiologic Features of Pneumonitis Induced by Anti‐PD‐1 Therapy
Cancer Medicine
Cancer Research
Nuclear Medicine
Radiology
Imaging
Oncology
Related publications
Recurrent Pneumonitis Induced by Atezolizumab (Anti–Programmed Death Ligand 1) in NSCLC Patients Who Previously Experienced Anti-Programmed Death 1 Immunotherapy-Related Pneumonitis
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Transcriptional Mechanisms of Resistance to Anti–PD-1 Therapy
Clinical Cancer Research
Cancer Research
Oncology
SCLE and Dermatomyositis in Anti‐PD‐1 Therapy
British Journal of Dermatology
Dermatology
Medicine
P1.13-32 Comparison Between Immune-Mediated Pneumonitis and Pneumonia in Patients Treated With PD-1/PD-L1 Therapy
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Effect of Combined Anti-Pd-1 and Temozolomide Therapy in Glioblastoma
OncoImmunology
Oncology
Allergy
Immunology
Rationale of Combination of Anti-Pd-1/Pd-L1 Antibody Therapy and Radiotherapy for Cancer Treatment
International Journal of Clinical Oncology
Medicine
Surgery
Oncology
Hematology
Diverse Cutaneous Adverse Eruptions Caused by Anti-Programmed Cell Death-1 (PD-1) and Anti-Programmed Cell Death Ligand-1 (PD-L1) Immunotherapies: Clinical Features and Management
Therapeutic Advances in Medical Oncology
Oncology
Anti-Pd-1 Antibody Therapy Potently Enhances the Eradication of Established Tumors by Gene-Modified T Cells
Clinical Cancer Research
Cancer Research
Oncology
Features of Prognostic Significance in Testicular Germ Cell Tumours.
Journal of Clinical Pathology
Medicine
Forensic Medicine
Pathology
